Phase 1 Study of OSI-930 in Cancer Patients

NCT00513851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: OSI-930
DRUG: OSI-930

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]